Back to News
Market Impact: 0.2
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
Source: zacks.com
Analyst InsightsCorporate Guidance & OutlookHealthcare & Biotech
Oscar Health (OSCR) was upgraded to Zacks Rank #1 (Strong Buy) on improving optimism around its earnings outlook. The upgrade could support near-term share-price upside, though the article provides no underlying earnings estimates or financial figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
OSCR0.75
More News
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- Street Calls of The Week
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores
- Seaport offers preliminary thoughts on Anthropic stock
- argenx reports positive phase 3 data for autoimmune myositis drug
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup